EP3722443A1 - Novel markers for prenatal diagnosis and monitoring - Google Patents
Novel markers for prenatal diagnosis and monitoring Download PDFInfo
- Publication number
- EP3722443A1 EP3722443A1 EP19214593.6A EP19214593A EP3722443A1 EP 3722443 A1 EP3722443 A1 EP 3722443A1 EP 19214593 A EP19214593 A EP 19214593A EP 3722443 A1 EP3722443 A1 EP 3722443A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- dna
- genomic sequence
- sequence
- pregnancy
- woman
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/10—Characterised by chemical treatment
- C12Q2523/125—Bisulfite(s)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Definitions
- Chromosome 21 open reading frame 29 (C21orf29) The methylation profiles of C21orf29 from 2 maternal blood cell samples were compared with those of 1 first-trimester and 2 third-trimester placental tissue samples collected from normal pregnancies as well as 2 first-trimester placental tissue samples from pregnancies where the fetus had trisomy 21. Cloning and bisulfite sequencing were performed and the methylation indices of the studied CpG sites in the placental tissues and maternal blood cells are summarized in Figure 9 . In general, the placenta is hypermethylated when compared to maternal blood cells.
- genomic contigs accession number, version, start and end nucleotide numbers
- GenBank accession number, version, start and end nucleotide numbers
- chromosome start and end nucleotide numbers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79745606P | 2006-05-03 | 2006-05-03 | |
US11/784,499 US7901884B2 (en) | 2006-05-03 | 2007-04-06 | Markers for prenatal diagnosis and monitoring |
EP16156063.6A EP3085792B1 (en) | 2006-05-03 | 2007-05-03 | Novel markers for prenatal diagnosis and monitoring |
EP11168611.9A EP2385142B1 (en) | 2006-05-03 | 2007-05-03 | Novel markers for prenatal diagnosis and monitoring |
PCT/GB2007/001627 WO2007132167A2 (en) | 2006-05-03 | 2007-05-03 | Novel fetal markers for prenatal diagnosis and monitoring |
EP07732660A EP2016191B1 (en) | 2006-05-03 | 2007-05-03 | Novel fetal markers for prenatal diagnosis and monitoring |
Related Parent Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16156063.6A Division EP3085792B1 (en) | 2006-05-03 | 2007-05-03 | Novel markers for prenatal diagnosis and monitoring |
EP16156063.6A Division-Into EP3085792B1 (en) | 2006-05-03 | 2007-05-03 | Novel markers for prenatal diagnosis and monitoring |
EP11168611.9A Division EP2385142B1 (en) | 2006-05-03 | 2007-05-03 | Novel markers for prenatal diagnosis and monitoring |
EP07732660A Division EP2016191B1 (en) | 2006-05-03 | 2007-05-03 | Novel fetal markers for prenatal diagnosis and monitoring |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3722443A1 true EP3722443A1 (en) | 2020-10-14 |
Family
ID=38694260
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19214593.6A Pending EP3722443A1 (en) | 2006-05-03 | 2007-05-03 | Novel markers for prenatal diagnosis and monitoring |
EP16156063.6A Active EP3085792B1 (en) | 2006-05-03 | 2007-05-03 | Novel markers for prenatal diagnosis and monitoring |
EP11168611.9A Active EP2385142B1 (en) | 2006-05-03 | 2007-05-03 | Novel markers for prenatal diagnosis and monitoring |
EP07732660A Active EP2016191B1 (en) | 2006-05-03 | 2007-05-03 | Novel fetal markers for prenatal diagnosis and monitoring |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16156063.6A Active EP3085792B1 (en) | 2006-05-03 | 2007-05-03 | Novel markers for prenatal diagnosis and monitoring |
EP11168611.9A Active EP2385142B1 (en) | 2006-05-03 | 2007-05-03 | Novel markers for prenatal diagnosis and monitoring |
EP07732660A Active EP2016191B1 (en) | 2006-05-03 | 2007-05-03 | Novel fetal markers for prenatal diagnosis and monitoring |
Country Status (13)
Country | Link |
---|---|
US (1) | US7901884B2 (ko) |
EP (4) | EP3722443A1 (ko) |
JP (1) | JP2009535050A (ko) |
KR (5) | KR102166398B1 (ko) |
CN (3) | CN107354218B (ko) |
AU (1) | AU2007251351B2 (ko) |
CA (1) | CA2651051C (ko) |
EA (1) | EA014274B1 (ko) |
HK (1) | HK1126250A1 (ko) |
IL (2) | IL194984A (ko) |
MX (1) | MX2008013930A (ko) |
NZ (2) | NZ596951A (ko) |
WO (1) | WO2007132167A2 (ko) |
Families Citing this family (113)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6927028B2 (en) | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US8515679B2 (en) | 2005-12-06 | 2013-08-20 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US8532930B2 (en) | 2005-11-26 | 2013-09-10 | Natera, Inc. | Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals |
US10083273B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
ES2739483T3 (es) | 2006-02-02 | 2020-01-31 | Univ Leland Stanford Junior | Detección genética fetal no invasiva mediante análisis digital |
BRPI0709545A2 (pt) * | 2006-03-06 | 2011-07-19 | Univ Columbia | amplificação especìfica de seqüência de dna fetal de uma mistura de origem fetal-maternal |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US20080070792A1 (en) | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
US8137912B2 (en) * | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
TWI335354B (en) * | 2006-09-27 | 2011-01-01 | Univ Hong Kong Chinese | Methods for the detection of the degree of the methylation of a target dna and kits |
PL2557520T3 (pl) * | 2007-07-23 | 2021-10-11 | The Chinese University Of Hong Kong | Określanie zaburzenia równowagi sekwencji kwasu nukleinowego |
US20100112590A1 (en) | 2007-07-23 | 2010-05-06 | The Chinese University Of Hong Kong | Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment |
US8748100B2 (en) | 2007-08-30 | 2014-06-10 | The Chinese University Of Hong Kong | Methods and kits for selectively amplifying, detecting or quantifying target DNA with specific end sequences |
SG10201704689XA (en) | 2008-01-18 | 2017-07-28 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
CA2717320A1 (en) | 2008-03-11 | 2009-09-17 | Sequenom, Inc. | Nucleic acid-based tests for prenatal gender determination |
WO2010003153A2 (en) * | 2008-07-03 | 2010-01-07 | Life Technologies Corporation | Methylation analysis of mate pairs |
CN102171565B (zh) | 2008-08-04 | 2015-04-29 | 纳特拉公司 | 等位基因调用和倍性调用的方法 |
EP3103871B1 (en) * | 2008-09-16 | 2020-07-29 | Sequenom, Inc. | Processes for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for fetal nucleic acid quantification |
US8476013B2 (en) * | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US8962247B2 (en) | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
PT2334812T (pt) | 2008-09-20 | 2017-03-29 | Univ Leland Stanford Junior | ¿diagnóstico não invasivo de aneuploidia fetal por sequenciação |
US20120040344A1 (en) * | 2009-01-30 | 2012-02-16 | Keith Malcolm Godfrey | PREDICTIVE USE OF CpG METHYLATION |
US9458503B2 (en) | 2009-07-02 | 2016-10-04 | Nucleix | Methods for distinguishing between natural and artificial DNA samples |
US8563242B2 (en) | 2009-08-11 | 2013-10-22 | The Chinese University Of Hong Kong | Method for detecting chromosomal aneuploidy |
AU2015252141A1 (en) * | 2009-09-16 | 2015-12-03 | Sequenom Center For Molecular Medicine | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
EP2473638B1 (en) | 2009-09-30 | 2017-08-09 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US9752187B2 (en) * | 2009-12-11 | 2017-09-05 | Nucleix | Categorization of DNA samples |
WO2011101728A2 (en) * | 2010-02-19 | 2011-08-25 | Nucleix | Identification of source of dna samples |
ES2577017T3 (es) * | 2009-12-22 | 2016-07-12 | Sequenom, Inc. | Procedimientos y kits para identificar la aneuploidia |
US20110312503A1 (en) | 2010-01-23 | 2011-12-22 | Artemis Health, Inc. | Methods of fetal abnormality detection |
ES2623156T3 (es) * | 2010-01-26 | 2017-07-10 | Nipd Genetics Ltd | Métodos y composiciones para el diagnóstico prenatal no invasivo de aneuploidías fetales |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
CA2798758C (en) | 2010-05-18 | 2019-05-07 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
KR20130041961A (ko) | 2010-07-23 | 2013-04-25 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 체액에서 질환 또는 상태의 특징을 검출하는 방법 |
AU2011280936A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
TW201209171A (en) | 2010-07-23 | 2012-03-01 | Harvard College | Methods of detecting diseases or conditions using phagocytic cells |
EP2596116A4 (en) | 2010-07-23 | 2014-03-19 | Harvard College | METHODS FOR DETECTION OF AUTOIMMUNE OR IMMUNE-RELATED DISEASES / PATHOLOGIES |
US11031095B2 (en) | 2010-08-06 | 2021-06-08 | Ariosa Diagnostics, Inc. | Assay systems for determination of fetal copy number variation |
US20140342940A1 (en) | 2011-01-25 | 2014-11-20 | Ariosa Diagnostics, Inc. | Detection of Target Nucleic Acids using Hybridization |
US10167508B2 (en) | 2010-08-06 | 2019-01-01 | Ariosa Diagnostics, Inc. | Detection of genetic abnormalities |
US10533223B2 (en) | 2010-08-06 | 2020-01-14 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
US20120034603A1 (en) | 2010-08-06 | 2012-02-09 | Tandem Diagnostics, Inc. | Ligation-based detection of genetic variants |
US8700338B2 (en) | 2011-01-25 | 2014-04-15 | Ariosa Diagnosis, Inc. | Risk calculation for evaluation of fetal aneuploidy |
US20130040375A1 (en) | 2011-08-08 | 2013-02-14 | Tandem Diagnotics, Inc. | Assay systems for genetic analysis |
US20130261003A1 (en) | 2010-08-06 | 2013-10-03 | Ariosa Diagnostics, In. | Ligation-based detection of genetic variants |
US11203786B2 (en) | 2010-08-06 | 2021-12-21 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
JP6328934B2 (ja) | 2010-12-22 | 2018-05-23 | ナテラ, インコーポレイテッド | 非侵襲性出生前親子鑑定法 |
US9994897B2 (en) | 2013-03-08 | 2018-06-12 | Ariosa Diagnostics, Inc. | Non-invasive fetal sex determination |
US11270781B2 (en) | 2011-01-25 | 2022-03-08 | Ariosa Diagnostics, Inc. | Statistical analysis for non-invasive sex chromosome aneuploidy determination |
US8756020B2 (en) | 2011-01-25 | 2014-06-17 | Ariosa Diagnostics, Inc. | Enhanced risk probabilities using biomolecule estimations |
US10131947B2 (en) | 2011-01-25 | 2018-11-20 | Ariosa Diagnostics, Inc. | Noninvasive detection of fetal aneuploidy in egg donor pregnancies |
AU2011358564B9 (en) | 2011-02-09 | 2017-07-13 | Natera, Inc | Methods for non-invasive prenatal ploidy calling |
EP3378954B1 (en) | 2011-04-29 | 2021-02-17 | Sequenom, Inc. | Quantification of a minority nucleic acid species |
US8712697B2 (en) | 2011-09-07 | 2014-04-29 | Ariosa Diagnostics, Inc. | Determination of copy number variations using binomial probability calculations |
EP4155401A1 (en) | 2012-03-02 | 2023-03-29 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9127317B2 (en) | 2012-03-02 | 2015-09-08 | Winthrop-University Hospital | Method for using probe based PCR detection to measure the levels of circulating demethylated β cell derived DNA as a measure of β cell loss in diabetes |
AU2013232123B2 (en) | 2012-03-13 | 2014-10-30 | The Chinese University Of Hong Kong | Methods for analyzing massively parallel sequencing data for noninvasive prenatal diagnosis |
WO2013163318A1 (en) * | 2012-04-24 | 2013-10-31 | Siemens Healthcare Diagnostics, Inc. | Pre-eclampsia screening methods |
RU2507269C2 (ru) * | 2012-05-11 | 2014-02-20 | ЗАО "Геноаналитика" | Технология определения трисомии хромосом методом секвенирования |
US10289800B2 (en) | 2012-05-21 | 2019-05-14 | Ariosa Diagnostics, Inc. | Processes for calculating phased fetal genomic sequences |
US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
CA2878979C (en) | 2012-07-13 | 2021-09-14 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US9206417B2 (en) | 2012-07-19 | 2015-12-08 | Ariosa Diagnostics, Inc. | Multiplexed sequential ligation-based detection of genetic variants |
CN104619858B (zh) * | 2012-07-31 | 2017-06-06 | 深圳华大基因股份有限公司 | 胎儿健康状态的无创性检测 |
US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
NZ717423A (en) * | 2012-09-20 | 2017-08-25 | Univ Hong Kong Chinese | Non-invasive determination of methylome of fetus or tumor from plasma |
US10706957B2 (en) | 2012-09-20 | 2020-07-07 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of tumor from plasma |
CA2897684C (en) * | 2013-02-28 | 2021-06-29 | The Chinese University Of Hong Kong | Maternal plasma transcriptome analysis by massively parallel rna sequencing |
EP2965077B1 (en) | 2013-03-09 | 2022-07-13 | Harry Stylli | Methods of detecting cancer |
EP3385717A3 (en) | 2013-03-09 | 2018-10-24 | Harry Stylli | Methods of detecting prostate cancer |
EP2971100A1 (en) | 2013-03-13 | 2016-01-20 | Sequenom, Inc. | Primers for dna methylation analysis |
WO2015048535A1 (en) | 2013-09-27 | 2015-04-02 | Natera, Inc. | Prenatal diagnostic resting standards |
US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
GB2520763A (en) | 2013-12-02 | 2015-06-03 | Vanadis Diagnostics Ab | Nucleic acid probe and method of detecting genomic fragments |
US11365447B2 (en) | 2014-03-13 | 2022-06-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
CN106460070B (zh) | 2014-04-21 | 2021-10-08 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
EP2942400A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Multiplex detection of DNA that originates from a specific cell-type |
RU2016147914A (ru) | 2014-05-09 | 2018-06-18 | Лайфкодекс Аг | Обнаружение днк, которая происходит из специфического клеточного типа, и относящиеся к нему способы |
EP2942401A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Detection of DNA that originates from a specific cell-type |
EP3191846A4 (en) | 2014-09-11 | 2018-06-13 | Harry Stylli | Methods of detecting prostate cancer |
US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
CA2986200A1 (en) | 2015-05-22 | 2016-12-01 | Nipd Genetics Public Company Limited | Multiplexed parallel analysis of targeted genomic regions for non-invasive prenatal testing |
US9476100B1 (en) | 2015-07-06 | 2016-10-25 | Nucleix Ltd. | Methods for diagnosing bladder cancer |
KR101678962B1 (ko) | 2015-08-21 | 2016-12-06 | 이승재 | 대규모 병렬형 게놈서열분석 방법을 이용한 비침습적 산전검사 장치 및 방법 |
DK3168309T3 (da) | 2015-11-10 | 2020-06-22 | Eurofins Lifecodexx Gmbh | Detektion af føtale kromosomale aneuploidier under anvendelse af dna-regioner med forskellig metylering mellem fosteret og det gravide hunkøn |
RU2642622C2 (ru) * | 2016-05-27 | 2018-01-25 | Общество С Ограниченной Ответственностью "Тестген" | Набор олигонуклеотидных праймеров и зондов и способ количественного определения фетальной днк в кровотоке беременной женщины на основе анализа гиперметилированных участков днк плода |
WO2018067517A1 (en) | 2016-10-04 | 2018-04-12 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
US10894976B2 (en) | 2017-02-21 | 2021-01-19 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
CN108504653A (zh) * | 2018-04-12 | 2018-09-07 | 东莞博奥木华基因科技有限公司 | 一种母体外周血血浆快速分离方法及其应用 |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
IL265451B (en) | 2019-03-18 | 2020-01-30 | Frumkin Dan | Methods and systems for the detection of methylation changes in DNA samples |
WO2021163163A1 (en) * | 2020-02-10 | 2021-08-19 | Palogen, Inc. | Nanopore device and methods of detecting and classifying charged particles using same |
KR102332540B1 (ko) * | 2020-07-02 | 2021-11-29 | 의료법인 성광의료재단 | 다운증후군 특이적인 후성학적 마커를 이용한 다운증후군 진단 방법 |
CN112034180B (zh) * | 2020-08-18 | 2021-09-24 | 四川大学华西第二医院 | 角蛋白1在异位妊娠中的应用和产品 |
EP4381099A1 (en) | 2021-08-02 | 2024-06-12 | Natera, Inc. | Methods for detecting neoplasm in pregnant women |
KR20230087853A (ko) * | 2021-12-10 | 2023-06-19 | 한양대학교 에리카산학협력단 | 산모의 카드뮴 노출에 의한 조산 발생 가능성 예측을 위한 cg21010642 메틸화 바이오마커 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6258540B1 (en) | 1997-03-04 | 2001-07-10 | Isis Innovation Limited | Non-invasive prenatal diagnosis |
US20030044388A1 (en) | 2001-08-31 | 2003-03-06 | The Chinese University Of Hong Kong | Methods for detecting DNA originating from different individuals |
US20030211522A1 (en) | 2002-01-18 | 2003-11-13 | Landes Gregory M. | Methods for fetal DNA detection and allele quantitation |
WO2005118852A2 (en) * | 2004-06-04 | 2005-12-15 | The Chinese University Of Hong Kong | A marker for prenatal diagnosis and monitoring |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6555358B1 (en) * | 1999-04-13 | 2003-04-29 | Merck & Co., Inc. | Polynucleotide encoding eimeria tenella cGMP dependent protein kinase |
US20040153635A1 (en) | 2002-12-30 | 2004-08-05 | Kaushik Shivnandan D. | Privileged-based qualification of branch trace store data |
CN101245376A (zh) | 2003-01-17 | 2008-08-20 | 香港中文大学 | 作为妊娠相关病症的诊断标志物的循环mRNA |
WO2004064629A1 (en) | 2003-01-21 | 2004-08-05 | Ehrfeld Miktotechnik Ag | Sensor system for detecting analytes in tear fluid |
CA2540141C (en) * | 2003-09-22 | 2012-09-04 | Trisogen Biotechnology Limited Partnership | Methods and kits useful for detecting an alteration in a locus copy number |
US20050282213A1 (en) | 2003-09-22 | 2005-12-22 | Trisogen Biotechnology Limited Partnership | Methods and kits useful for detecting an alteration in a locus copy number |
-
2007
- 2007-04-06 US US11/784,499 patent/US7901884B2/en active Active
- 2007-05-03 NZ NZ596951A patent/NZ596951A/xx unknown
- 2007-05-03 EP EP19214593.6A patent/EP3722443A1/en active Pending
- 2007-05-03 KR KR1020197012577A patent/KR102166398B1/ko active IP Right Grant
- 2007-05-03 EA EA200802272A patent/EA014274B1/ru unknown
- 2007-05-03 JP JP2009508462A patent/JP2009535050A/ja active Pending
- 2007-05-03 NZ NZ572581A patent/NZ572581A/en unknown
- 2007-05-03 CN CN201710692457.7A patent/CN107354218B/zh active Active
- 2007-05-03 EP EP16156063.6A patent/EP3085792B1/en active Active
- 2007-05-03 CA CA2651051A patent/CA2651051C/en active Active
- 2007-05-03 EP EP11168611.9A patent/EP2385142B1/en active Active
- 2007-05-03 MX MX2008013930A patent/MX2008013930A/es active IP Right Grant
- 2007-05-03 KR KR1020087029578A patent/KR101456306B1/ko active IP Right Grant
- 2007-05-03 KR KR1020207009262A patent/KR102221745B1/ko active IP Right Grant
- 2007-05-03 KR KR1020187015010A patent/KR102129690B1/ko active IP Right Grant
- 2007-05-03 EP EP07732660A patent/EP2016191B1/en active Active
- 2007-05-03 KR KR1020147020590A patent/KR101864921B1/ko active IP Right Grant
- 2007-05-03 WO PCT/GB2007/001627 patent/WO2007132167A2/en active Application Filing
- 2007-05-03 AU AU2007251351A patent/AU2007251351B2/en active Active
- 2007-05-03 CN CN2007800232878A patent/CN101535502B/zh active Active
- 2007-05-03 CN CN201210228385.8A patent/CN102758014B/zh active Active
-
2008
- 2008-10-29 IL IL194984A patent/IL194984A/en active IP Right Grant
-
2009
- 2009-05-14 HK HK09104396.3A patent/HK1126250A1/xx not_active IP Right Cessation
-
2012
- 2012-05-28 IL IL220019A patent/IL220019A/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6258540B1 (en) | 1997-03-04 | 2001-07-10 | Isis Innovation Limited | Non-invasive prenatal diagnosis |
US20030044388A1 (en) | 2001-08-31 | 2003-03-06 | The Chinese University Of Hong Kong | Methods for detecting DNA originating from different individuals |
US20030211522A1 (en) | 2002-01-18 | 2003-11-13 | Landes Gregory M. | Methods for fetal DNA detection and allele quantitation |
WO2005118852A2 (en) * | 2004-06-04 | 2005-12-15 | The Chinese University Of Hong Kong | A marker for prenatal diagnosis and monitoring |
Non-Patent Citations (38)
Title |
---|
"Current Protocols in Molecular Biology", 1994 |
AMICUCCI ET AL., CLIN. CHEM., vol. 46, 2000, pages 301 - 302 |
BATZER ET AL., NUCLEIC ACID RES., vol. 19, 1991, pages 5081 |
BEAUCAGECARUTHERS, TETRAHEDRON LETT., vol. 22, 1981, pages 1859 - 1862 |
CHIM ET AL., PROC NATL ACAD SCI USA., vol. 102, pages 14753 - 14758 |
CHIU ET AL., LANCET, vol. 360, 2002, pages 998 - 1000 |
COSTA ET AL., N. ENGL. J. MED., vol. 346, 2002, pages 1502 |
E. MERSY ET AL: "Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012", HUMAN REPRODUCTION UPDATE, vol. 19, no. 4, 1 July 2013 (2013-07-01), GB, pages 318 - 329, XP055293617, ISSN: 1355-4786, DOI: 10.1093/humupd/dmt001 * |
FLORI ET AL., HUM REPROD, vol. 19, 2004, pages 723 - 724 |
HERMAN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 93, 1996, pages 9821 - 9826 |
INNIS ET AL.: "PCR Protocols: A Guide to Methods and Applications", 1990, ACADEMIC PRESS, INC. |
JI HYAE LIM ET AL: "Non-Invasive Epigenetic Detection of Fetal Trisomy 21 in First Trimester Maternal Plasma", PLOS ONE, vol. 6, no. 11, 23 November 2011 (2011-11-23), pages e27709, XP055293613, DOI: 10.1371/journal.pone.0027709 * |
JOHANSEN ET AL., PRENAT. DIAGN., vol. 15, 1995, pages 921 - 931 |
KRIEGLER, GENE TRANSFER AND EXPRESSION: A LABORATORY MANUAL, 1990 |
LO ET AL., CLIN. CHEM., vol. 45, 1999, pages 1747 - 1751 |
LO ET AL., LANCET, vol. 350, 1997, pages 485 - 487 |
LO ET AL., N. ENGL. J. MED., vol. 339, 1998, pages 1734 - 1738 |
LUI ET AL., CLIN CHEM, vol. 48, 2002, pages 421 - 427 |
MASUZAKI ET AL., JMED GENET, vol. 41, 2004, pages 289 - 292 |
NG ET AL., PROC. NATL. ACAD. SCI. USA, vol. 100, 2003, pages 4748 - 4753 |
NOLTE, ADV. CLIN. CHEM., vol. 33, 1998, pages 201 - 235 |
OHTSUKA ET AL., J. BIOL. CHEM., vol. 260, 1985, pages 2605 - 2608 |
PEARSONREANIER, J CHROM., vol. 255, 1983, pages 137 - 149 |
POON ET AL., CLIN. CHEM., vol. 48, 2002, pages 421 - 427 |
POON L.L.M. ET AL.: "Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma", CLINICAL CHEMISTRY, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC, US, vol. 48, no. 1, January 2002 (2002-01-01), pages 35 - 41, XP002247509, ISSN: 0009-9147 * |
ROSSOLINI ET AL., MOL. CELL. PROBES, vol. 8, 1994, pages 91 - 98 |
SAITO ET AL., LANCET, vol. 356, 2000, pages 1170 |
SAMBROOKRUSSELL: "Molecular Cloning: A Laboratory Manual", 2001 |
SEKIZAWA ET AL., CLIN. CHEM., vol. 47, 2001, pages 2164 - 2165 |
TABOR ET AL., LANCET, vol. 1, 1986, pages 1287 - 1293 |
TAKAI ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 99, 2002, pages 3740 - 3745 |
VAN DEVANTER, NUCLEIC ACIDS RES., vol. 12, 1984, pages 6159 - 6168 |
WALLACE ET AL., GENE, vol. 16, 1981, pages 21 - 26 |
XIONGLAIRD, NUCLEIC ACIDS RES, vol. 25, 1997, pages 2532 - 2534 |
YAMADA ET AL., GENOME RES, vol. 14, 2004, pages 247 - 266 |
YAMADA ET AL., GENOME RESEARCH, vol. 14, 2004, pages 247 - 266 |
ZHONG ET AL., AM. J. OBSTET. GYNECOL., vol. 184, 2001, pages 414 - 419 |
ZHONG ET AL., PRENAT. DIAGN., vol. 20, 2000, pages 795 - 798 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3085792B1 (en) | Novel markers for prenatal diagnosis and monitoring | |
US11597977B2 (en) | Marker for prenatal diagnosis and monitoring | |
EP3505644B1 (en) | New fetal methylation marker | |
BRPI0711273A2 (pt) | métodos para detectar ou monitorar um distúrbio associado com a gravidez, e para detectar a trissomia 21 em um feto em uma mulher grávida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
AC | Divisional application: reference to earlier application |
Ref document number: 3085792 Country of ref document: EP Kind code of ref document: P Ref document number: 2385142 Country of ref document: EP Kind code of ref document: P Ref document number: 2016191 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20201214 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20211222 |